Trials / Recruiting
RecruitingNCT06088472
TIL Injection for the Treatment of Metastatic or Recurrent Solid Tumors
A Single-arm Phase I Clinical Study of TIL Injection for the Treatment of Metastatic or Recurrent Solid Tumors
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Grit Biotechnology · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a single-center, single-arm phase I clinical trial.The study process was divided into: screening period, sampling and production period, NMA-LD chemotherapy , treatment and observation period, and follow-up period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | TIL injection | Autologous tumor infiltrating lymphocyte injection |
Timeline
- Start date
- 2021-04-21
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
- First posted
- 2023-10-18
- Last updated
- 2025-09-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06088472. Inclusion in this directory is not an endorsement.